Regulation of bone mass in endocrine diseases including diabetes-Reference-Cited by-同舟云学术

Regulation of bone mass in endocrine diseases including diabetes

Published:2022-03 Issue:2 Volume:36 Page:101614
ISSN:1521-690X
Container-title:Best Practice & Research Clinical Endocrinology & Metabolism
language:en
Short-container-title:Best Practice & Research Clinical Endocrinology & Metabolism

Author:

Higham Claire^ORCID,Abrahamsen Bo^ORCID

Funder

UCB

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference104 articles.

1. Skeletal changes through the lifespan—from growth to senescence;Farr;Nat Rev Endocrinol,2015

2. Expanding the role of thyroid-stimulating hormone in skeletal physiology;Baliram;Front Endocrinol,2017

3. Thyroid diseases and bone health;Williams;J Endocrinol Invest,2018

4. A tetracycline-based histomorphometric evaluation of bone resorption and bone turnover in hyperthyroidism and hyperparathyroidism;Mosekilde;Acta Med Scand,1978

5. Bone indices in thyroidectomized patients on long-term substitution therapy with levothyroxine assessed by DXA and HR-pQCT;Moser;J Thyroid Res,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the effect of Dapagliflozin and Pioglitazone on the risk of osteoporosis in postmenopausal women with Type-2 diabetes;Pakistan Journal of Medical Sciences;2023-07-12

2. New Insights in the Pathophysiology, Epidemiology, and Response to Treatment of Osteoporotic Vertebral Fractures;The Journal of Clinical Endocrinology & Metabolism;2023-05-15

3. Artificial Intelligence Mechanism to Predict the Effect of Bone Mineral Densıty in Endocrıne Diseases—A Review;Lecture Notes in Networks and Systems;2023

4. The Impact of Environmental and Genetic Factors on Bone Quality in Monozygotic and Dizygotic Twins;Biomedicines;2022-09-22